Ambry Genetics Competitors and Similar CompaniesClear all
Ambry Genetics's competitors and similar companies include National Genetics Institute, Asuragen, Invitae, Biora Therapeutics, Color, 23andMe, Myriad Genetics and Natera.
 National Genetics Institute National Genetics Institute (NGI) is a company that provides genetics testing services for blood screening, medical testing, and clinical research. |  Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services. |  23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. |  Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ||||||
Founding Date | Founding Date 1999 | Founding Date 1991 | Founding Date 2006 | Founding Date 2010 | Founding Date 2010 | Founding Date 2013 | Founding Date 2006 | Founding Date 1991 | Founding Date 2004 |
Type | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Aliso Viejo, US HQ Aliso Viejo, US | Locations Los Angeles, US HQ | Locations Austin, US HQ | Locations San Francisco, US HQ | Locations San Diego, US HQ San Diego, US | Locations Burlingame, US HQ | Locations Sunnyvale, US HQ South San Francisco, US | Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH | Locations Austin, US HQ San Carlos, US |
Employees | Employees 9094% increase | Employees 65 | Employees 1282% increase | Employees 8601% decrease | Employees 5456% decrease | Employees 6051% increase | Employees 56027% decrease | Employees 2,700 | Employees 3,28211% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 16.4 m | Valuation ($) 1.5 b | Valuation ($) 169.1 m | Valuation ($) 2 b | Valuation ($) 15.4 b |
Financial | |||||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $516.3m (FY, 2022) | Revenue (est.) $4k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $189.9m (FY, 2025) | Revenue (est.) $824.5m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $417.3m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods $89.9m (FY, 2025) | Cost of goods $247.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $99m (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit $100m (FY, 2025) | Gross profit $576.6m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($3.1b) (FY, 2022) | Net income ($124.1m) (FY, 2023) | Net income N/A | Net income ($280.9m) (FY, 2025) | Net income ($365.9m) (FY, 2025) | Net income ($208.2m) (FY, 2025) |
Operating ⚠ | |||||||||
Facilities Leased, sq. ft. | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. 500.1 k (FY, 2022) | Facilities Leased, sq. ft. 272 k (FY, 2021) |
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications 7 (Apr, 2020) | Patent Applications N/A | Patent Applications 100 (FY, 2021) |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued N/A | Patents Issued 93 (FY, 2022) | Patents Issued N/A | Patents Issued 200 (FY, 2021) |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A | Products 6 (Jul, 2022) | Products N/A | Products 10 (FY, 2021) | Products N/A |
Trademark Applications (US) | Trademark Applications (US) 6 (Aug, 2022) | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) 5 (Jul, 2022) | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) N/A |
Trademarks (US) | Trademarks (US) 65 (Aug, 2022) | Trademarks (US) 3 (Nov, 2022) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) 3 (Jul, 2022) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A |
Funding | |||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 80m | Total funding raised $ 363.1m | Total funding raised $ 138.5m | Total funding raised $ 396m | Total funding raised $ 912.5m | Total funding raised N/A | Total funding raised $ 154.1m |
For sources of this data, please see the company profile
View Company Profiles
National Genetics Institute
HQ
Los Angeles, US
National Genetics Institute (NGI) is a company that provides genetics testing services for blood screening, medical testing, and clinical research.
View companyBiora Therapeutics
HQ
San Diego, US
Employees
54
Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services.
View company